Ceftazidim + solvent lidocaine hydrochloride

powder+solution 5 ml

international nonproprietary name

Ceftazidime

Ref

BM-0220

Pharmacotherapeutic group

Not established

Composition of the preparation

Not established

Pharmacological action

Not established

Indications

Not established

Special indication

Not established

Special warning

Not established

Dosage and method of administration

1 g + 10 mg/ml

Overdosage

Not established

Safety measures

Not established

Side effects

Not established

Contraindications

Not established

Interactions with other medicinal preparations

Not established

The form of release

powder + solution 5 ml – amount in packaging : 1+1